EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische Studie

QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients

Ido Goldenberg, Mehmet K Aktas, Wojciech Zareba, David Tsu-Chau Huang, Spencer Z Rosero, Arwa Younis, Scott McNitt, Martin Stockburger, Jonathan S Steinberg, Rupinder S Buttar, Bela Merkely, Valentina Kutyifa

JACC: Clinical Electrophysiology · 2024-01 · 10 (1) · 16-26

DOI: 10.1016/j.jacep.2023.09.018 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2024-01. Verfasst von Ido Goldenberg und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester Medical Center, Rochester, New York, USA; Rochester General Hospital, Rochester, New York, USA. Electronic address: cedricgol…. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Defibrillators, Implantable, Tachycardia, Ventricular. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There are conflicting data on the effect of cardiac resynchronization therapy with a defibrillator (CRT-D) on the risk of life-threatening ventricular tachyarrhythmia in heart failure patients. OBJECTIVES: The authors aimed to assess whether QRS morphology is associated with risk of ventricular arrhythmias in CRT recipients. METHODS: The study population comprised 2,862 patients implanted with implantable cardioverter defibrillator (ICD)/CRT-D for primary prevention who were enrolled in 5 landmark primary prevention ICD trials (MADIT-II [Multicenter Automated Defibrillator Implantation Trial], MADIT-CRT [Multicenter Automated Defibrillator Implantation Trial-Cardiac Resynchronization Therapy], MADIT-RIT [Multicenter Automated Defibrillator Implantation Trial-Reduction in Inappropriate Therapy], MADIT-RISK [Multicenter Automated Defibrillator Implantation Trial-RISK], and RAID [Ranolazine in High-Risk Patients With Implanted Cardioverter Defibrillators]). Patients with QRS duration ≥130 ms were divided into 2 groups: those implanted with an ICD only vs CRT-D. The primary endpoint was fast ventricular tachycardia (VT)/ventricular fibrillation (VF) (defined as VT ≥200 beats/min or VF), accounting for the competing risk of death. Secondary endpoints included appropriate shocks, any sustained VT or VF, and the burden of fast VT/VF, assessed in a recurrent event analysis. RESULTS: Among patients with left bundle branch block (n = 1,792), those with CRT-D (n = 1,112) experienced a significant 44% (P < 0.001) reduction in the risk of fast VT/VF compared with ICD-only patients (n = 680), a significantly lower burden of fast VT/VF (HR: 0.55; P = 0.001), with a reduced burden of appropriate shocks (HR: 0.44; P < 0.001). In contrast, among patients with non-left bundle branch block (NLBBB) (N = 1,070), CRT-D was not associated with reduction in fast VT/VF (HR: 1.33; P = 0.195). Furthermore, NLBBB patients with CRT-D experienced a statistically significant increase in the burden of fast VT/VF events compared with ICD-only patients (HR: 1.90; P = 0.013). CONCLUSIONS: Our data suggest a potential proarrhythmic effect of CRT among patients with NLBBB. These data should be considered in patient selection for treatment with CRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Resynchronization TherapyDefibrillators, ImplantableTachycardia, VentricularHumansArrhythmias, CardiacBundle-Branch BlockTreatment OutcomeVentricular Fibrillation

Stichwörter der Autor:innen

cardiac resynchronization therapyimplantable cardioverter defibrillatorventricular arrhythmia burdenventricular fibrillationventricular tachycardia

Autor:innen und Institutionen

  • University of Rochester Medical Center, Rochester, New York, USA; Rochester General Hospital, Rochester, New York, USA. Electronic address: cedricgold91@gmail.com.
  • University of Rochester Medical Center, Rochester, New York, USA.
  • Charite, Berlin, Germany.
  • Rochester General Hospital, Rochester, New York, USA.
  • Semmelweis University, Heart Center, Budapest, Hungary.
  • University of Rochester Medical Center, Rochester, New York, USA; Semmelweis University, Heart Center, Budapest, Hungary.

Zitieren

APA

Goldenberg, I., Aktas, M. K., Zareba, W., Tsu-Chau Huang, D., Rosero, S. Z., Younis, A., McNitt, S., Stockburger, M., Steinberg, J. S., Buttar, R. S., Merkely, B., & Kutyifa, V. (2024). QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients. JACC: Clinical Electrophysiology, 10(1), 16-26. https://doi.org/10.1016/j.jacep.2023.09.018

Vancouver

Goldenberg I, Aktas MK, Zareba W, Tsu-Chau Huang D, Rosero SZ, Younis A, et al. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients. JACC: Clinical Electrophysiology. 2024;10(1):16-26. doi:10.1016/j.jacep.2023.09.018

BibTeX
@article{Goldenberg2024,
  author = {Goldenberg, Ido and Aktas, Mehmet K and Zareba, Wojciech and Tsu-Chau Huang, David and Rosero, Spencer Z and Younis, Arwa and McNitt, Scott and Stockburger, Martin and Steinberg, Jonathan S and Buttar, Rupinder S and Merkely, Bela and Kutyifa, Valentina},
  title = {QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {1},
  pages = {16--26},
  doi = {10.1016/j.jacep.2023.09.018}
}
Kostenlos starten →